Aurinia’s Patent Settlement with Teva Secures Voclosporin Exclusivity Until 2036
Market Chameleon (Thu, 20-Aug 9:42 AM)
Aurinia Pharmaceuticals Reports 74% Net Income Growth and Initiates New Lupus Nephritis Study—Is the Pace Sustainable?
Market Chameleon (Thu, 6-Aug 8:43 AM)
